Fatty acid transport and mitochondrial oxidation disorders

Seminars in Liver Disease

Volumn 21, Issue 4, 2001, Pages 489-500

  Rinaldo, P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Liver failure; Maternal complications of pregnancy; Newborn screening; Sudden death

Indexed keywords

ACYL COENZYME A; ACYLCARNITINE; AMMONIA; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LACTIC ACID; LONG CHAIN FATTY ACID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MESSENGER RNA; URIC ACID;

CLINICAL FEATURE; FATTY ACID TRANSPORT; HUMAN; HUMAN CELL; LABORATORY DIAGNOSIS; LIVER DISEASE; LIVER FAILURE; MITOCHONDRIAL RESPIRATION; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME;

BIOLOGICAL TRANSPORT; FATTY ACIDS; FEMALE; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; LIVER FAILURE, ACUTE; MITOCHONDRIA, LIVER; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0035203147     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-19037     Document Type: Review

References (62)

1. Fatty acid regulation of gene expression
2. Mammalian mitochondrial β-oxidation
3. Mechanisms of cellular uptake of long chain free fatty acids
4. Fatty acid transport proteins: A current view of a growing family
5. The role of carnitine in cell metabolism
6. Molecular enzymology of carnitine transfer and transport
7. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis
8. Regulation of hepatic fatty acid oxidation and ketone body production
9. Inborn errors of ketone body metabolism
10. Approach to the patient with a fatty acid oxidation disorder
11. Fatty acid oxidation disorders: Clinical and biochemical features
12. Inborn errors of mitochondrial fatty acid oxidation
13. Disorders of fatty acid transport and mitochondrial oxidation: Challenges and dilemmas of metabolic evaluation
14. Inborn defects in mitochondrial fatty acid oxidation
15. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels
16. Incidence of Reye's syndrome in France: A hospital-based survey
17. Retrospective biochemical screening of fatty acid oxidation disorders in post-mortem liver of 418 cases of sudden unexpected death in the first year of life
18. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death
19. Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome
20. A defect in the transport of long-chain fatty acids associated with acute liver failure
21. A fetal fatty acid oxidation disorder causes maternal liver disease of pregnancy
22. Liver disease in pregnancy
23. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation
24. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia
25. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis
26. Ketone body metabolism in the mother and fetus
27. Lipid metabolism in the fetus and the newborn
28. Fatty acid oxidation (FAO) in normal human placenta: Developmental expression and activity of enzymes of mitochondrial β-oxidation
29. Fatty acid oxidation disorders
30. Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications
31. Laboratory diagnosis of inborn errors of metabolism
32. Ketonuria and medium-chain acyl-CoA dehydrogenase deficiency
33. Quantitative determination of plasma C8-C26 total fatty acids for the bio chemical diagnosis of nutritional and metabolic disorders
34. An improved method for measuring serum or plasma free 3-hydroxy-fatty acids using stable isotope dilution gas chromatography-mass spectrometry and its utility for the study of disorders of mitochondrial fatty acid β-oxidation
35. The fasting test in paediatrics: Application to the diagnosis of pathological hypo and hyperketotic states
36. 3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts
37. Stability of long-chain and short-chain 3-hydroxyacyl-CoA dehydrogenase activity in postmortem liver
38. Acylcarnitines produced in vitro by cultured fibroblasts of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency and other disorders of fatty acid oxidation
39. Complementation analysis of fatty acid oxidation disorders
40. Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis
41. Rapid diagnosis of MCAD deficiency: Quantitatively analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry
42. Retrospective diagnosis of very long chain acyl-CoA dehydrogenase deficiency from an infant's newborn screening card
43. Tandem mass spectrometry in newborn screening
44. Medium chain acyl-coenzyme A (MCAD) deficiency
45. Sudden adult death and medium-chain acyl-CoA dehydrogenase deficiency
46. Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children
47. Sudden and unexpected neonatal death: A protocol for the postmortem diagnosis of fatty acid oxidation disorders
48. The metabolic autopsy comes of age
49. Complementation analysis of six patients with a defect of long-chain fatty acid transport in fibroblasts
50. Synergistic heterozygosity: Disease resulting from multiple partial defects in one or more metabolic pathways
51. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations
52. L-3-hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. Purification and properties
53. Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver
54. Occurrence of two 3-hydroxyacyl-CoA dehydrogenases in rat liver
55. Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: Cloning and characterization of the coding sequence
56. Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: A new cause of recurrent myoglobinuria and encephalopathy
57. Mitochondrial short-chain L-3-hydroxybutyryl-CoA dehydrogenase deficiency: A new defect of fatty acid oxidation
58. Fatal hepatic short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: Clinical, biochemical, and pathological studies on three subjects with this recently identified disorder of mitochondrial beta-oxidation
59. A mouse model for medium and short chain L-3-hydroxyacyl-CoA dehydrogenase deficiency
60. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion
61. Fulminant hepatic failure associated with mutations in the medium and short chain L-3-hydroxyacyl-CoA dehydrogenase gene
62. Phenotypes of patients with "simple" Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics